Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Harbin
Clinical trial register · China

Clinical Trials in Harbin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5 Xiamen 3 Guangzhou 3 Changsha 3 Shanghai 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Harbin Medical University24 AstraZeneca23 Eli Lilly and Company21 Hoffmann-La Roche15 BeOne Medicines15 Merck Sharp & Dohme LLC14 Bristol-Myers Squibb14 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.11 Amgen10 Daiichi Sankyo9 Akeso8 Pfizer8 Novartis Pharmaceuticals8 First Affiliated Hospital of Harbin Medical University8 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.8 Shanghai Junshi Bioscience Co., Ltd.7 Boehringer Ingelheim6 Janssen Research & Development, LLC6 MediLink Therapeutics (Suzhou) Co., Ltd.6 Peking University People's Hospital6 AbbVie6 Abbisko Therapeutics Co, Ltd6 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.5 Sanofi5 Jiangsu HengRui Medicine Co., Ltd.5 Biotheus Inc.5 Nanjing Leads Biolabs Co.,Ltd5 Allist Pharmaceuticals, Inc.4 Sichuan Baili Pharmaceutical Co., Ltd.4 RemeGen Co., Ltd.4 Novo Nordisk A/S4 Shanghai Pharmaceuticals Holding Co., Ltd4 Peking Union Medical College Hospital4 First Affiliated Hospital of Zhejiang University4 Eye & ENT Hospital of Fudan University4 Shandong Suncadia Medicine Co., Ltd.4 Hansoh BioMedical R&D Company4 Shanghai Zhongshan Hospital4 Beijing Anzhen Hospital4 Jiangsu Simcere Pharmaceutical Co., Ltd.3 Dizal Pharmaceuticals3 Bayer3 Teligene US3 Gilead Sciences3 BeiGene3 Shanghai Henlius Biotech3 CSPC Megalith Biopharmaceutical Co.,Ltd.3 DualityBio Inc.3 Fudan University3 Genmab3 Huashan Hospital3 Capital Medical University3 D3 Bio (Wuxi) Co., Ltd3 Beijing QL Biopharmaceutical Co.,Ltd2 Xuanwu Hospital, Beijing2 Xiamen Amoytop Biotech Co., Ltd.2 Astellas Pharma Global Development, Inc.2 First Affiliated Hospital of Ningbo University2 Hangzhou Endonom Medtech Co., Ltd.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 Guang'anmen Hospital of China Academy of Chinese Medical Sciences2 Zai Lab (Shanghai) Co., Ltd.2 Second Xiangya Hospital of Central South University2 Beijing InnoCare Pharma Tech Co., Ltd.2 Air Force Military Medical University, China2 Takeda2 Haihe Biopharma Co., Ltd.2 Acerta Pharma BV2 ADARx Pharmaceuticals, Inc.2 The Third Affiliated Hospital of Harbin Medical University2 Betta Pharmaceuticals Co., Ltd.2 Avistone Biotechnology Co., Ltd.2 Vantive Health LLC2 Medtronic2 Jinwei Tian2 EMD Serono Research & Development Institute, Inc.2 Shengjing Hospital2 West China Hospital2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Institute of Hematology & Blood Diseases Hospital, China2 Huabo Biopharm Co., Ltd.2 Sun Yat-sen University2 Beijing Tiantan Hospital2 Celgene2 Qilu Pharmaceutical Co., Ltd.2 Daehwa Pharmaceutical Co., Ltd.1 Ying Gao1 Sinomed Neurovita Technology Inc.1 Bisirna Therapeutics (Suzhou) Co., Ltd.1 Xi Shan Wang1 Fortvita Biologics (USA)Inc.1 Klus Pharma Inc.1 Children's Hospital of Fudan University1 JiaRay Group1 Innostellar Biotherapeutics Co.,Ltd1 Shanghai Hongdian Medical CO., LTD1 Beijing Pins Medical Co., Ltd1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 Exelixis1 Mirati Therapeutics Inc.1 Xuanzhu Biopharmaceutical Co., Ltd.1 Genuine Seed Therapeutics (Zhuhai) Co., Ltd.1 Integra LifeSciences Corporation1 Shanghai Best-Link Bioscience, LLC1 Turning Point Therapeutics, Inc.1 CStone Pharmaceuticals1 Jianmin Pharmaceutical Group Co., LTD.1 Fujian Medical University1 Second Affiliated Hospital of Nanchang University1 Beidahuang Industry Group General Hospital1 Cytokinetics1 Heronova Pharmaceuticals1 Corxel Pharmaceuticals1 Avenzo Therapeutics, Inc.1 Gan Lijun1 Medtronic Cardiac Ablation Solutions1 The Second Hospital of Anhui Medical University1 First Hospital of China Medical University1 Henan Genuine Biotech Co., Ltd.1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Kylonova (Xiamen) Biopharma co., LTD.1 Tianjin Medical University General Hospital1 Shenzhen Majory Biotechnology Co., Ltd.1 Chunyan Ma1 Summit Therapeutics1 Shandong Boan Biotechnology Co., Ltd1 Chinese PLA General Hospital1 Haisco Pharmaceutical Group Co., Ltd.1 Second Affiliated Hospital, Zhejiang University, School of Medicine1 Jiangsu Hansoh Pharmaceutical Co., Ltd.1 Hangzhou Sumgen Biotech Co., Ltd.1 PersonGen BioTherapeutics (Suzhou) Co., Ltd.1 Peking University1 InventisBio Co., Ltd1 PharmaEssentia1 Genfleet Therapeutics (Shanghai) Inc.1 Prime Gene Therapeutics Co., Ltd.1 Lixiaoling1 Loxo Oncology, Inc.1 Tianjin Medical University Cancer Institute and Hospital1 Dizal (Jiangsu) Pharmaceutical Co., Ltd.1 Multitude Therapeutics Inc.1 Xynomic Pharmaceuticals, Inc.1 Xilin Sun1 Hutchmed1 Singlomics Biopharmaceuticals Zhuhai Co., Ltd.1 Vividion Therapeutics, Inc.1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Beijing Hospital1 Genentech, Inc.1 The First Hospital of Jilin University1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Shanghai Changzheng Hospital1 Shanghai Mental Health Center1 Shanghai SciBrunch Therapeutics Co., Ltd.1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 Evopoint Biosciences Inc.1 Peking University Hospital of Stomatology1 Tang-Du Hospital1 Permed Biomedical Engineering Co., Ltd1 ArriVent BioPharma, Inc.1 RenJi Hospital1 Peking University First Hospital1 Huahui Health1 Servier Bio-Innovation LLC1 Beijing Inno Medicine Co., Ltd.1 SUNHO(China)BioPharmaceutical CO., Ltd.1 Shanghai Allink Biotherapeutics Co., Ltd.1 CARsgen Therapeutics Co., Ltd.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 Seagen, a wholly owned subsidiary of Pfizer1 GV20 Therapeutics1 MSD R&D (China) Co., Ltd.1 Nanjing Medical University1 Beijing University of Chinese Medicine1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 Jazz Pharmaceuticals1 Jiangsu Healthy Life Innovation Medical Technology Co., Ltd1 Wuhan YZY Biopharma Co., Ltd.1 Haibo Shao1 Newish Technology (Beijing) Co., Ltd.1 CSPC Ouyi Pharmaceutical Co., Ltd.1 China Medical University, China1 Binhui Biopharmaceutical Co., Ltd.1 Affiliated Hospital of Changchun University of Chinese Medicine1 Alexion Pharmaceuticals, Inc.1 OBI Pharma, Inc1 Dr. Willmar Schwabe GmbH & Co. KG1 Innovent Biologics (Suzhou) Co. Ltd.1 Excyte Biopharma Ltd1 I-Mab Biopharma US Limited1 Beijing Shijitan Hospital, Capital Medical University1 Ribotek Biopharmaceuticals (Shandong) Co., Ltd1 Dermavon Holdings Limited1 Regeneron Pharmaceuticals1 Guangzhou Gloria Biosciences Co., Ltd.1 Yanqiao Zhang1 Guangzhou Sinogen Pharmaceutical Co., Ltd1 Jacobio Pharmaceuticals Co., Ltd.1 Shanghai Jiao Tong University School of Medicine1 magAssist, Inc.1 Arrowhead Pharmaceuticals1 BioNTech SE1 GlaxoSmithKline1 Third Military Medical University1 Eddingpharm (Zhuhai) Co., Ltd.1 3D Medicines (Sichuan) Co., Ltd.1 TransThera Sciences (Nanjing), Inc.1 Shanghai Chest Hospital1 Taiho Oncology, Inc.1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 Zhao Minghui1 B. Braun Medical International Trading Company Ltd.1 Adlai Nortye Biopharma Co., Ltd.1 Zhejiang Haichang Biotech Co., Ltd.1 Clear sponsor filter
Target enrolment
to

Trials with a site in Harbin

2 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1/2
166
Beijing, Xiamen, Guangzhou, Harbin, Changsha, Changchun, Shanghai
2025-05-12
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
339
Hefei, Beijing, Xiamen, Guangzhou, Harbin, Zhengzhou, Wuhan, Changsha
2024-01-23
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/harbin

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Harbin that also match the filters currently applied.

How many clinical trials are recruiting in Harbin?

2 of the 2 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Harbin), 2 studies
PhaseStudiesRecruitingShare
Phase 11150%
Phase 1/21150%

Most active sponsors

Lead sponsors with the most studies (Harbin)
Lead sponsorStudiesRecruiting
Zai Lab (Shanghai) Co., Ltd.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.